Literature DB >> 28639753

Screening for ovarian cancer: imaging challenges and opportunities for improvement.

K B Mathieu1, D G Bedi2, S L Thrower1, A Qayyum2, R C Bast3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 28639753      PMCID： PMC5788737          DOI： 10.1002/uog.17557

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN： 0960-7692            Impact factor:   7.299


× No keyword cloud information.
  137 in total

Review 1.  Magnetorelaxometry procedures for quantitative imaging and characterization of magnetic nanoparticles in biomedical applications.

Authors:  Maik Liebl; Frank Wiekhorst; Dietmar Eberbeck; Patricia Radon; Dirk Gutkelch; Daniel Baumgarten; Uwe Steinhoff; Lutz Trahms
Journal:  Biomed Tech (Berl)       Date:  2015-10       Impact factor: 1.411

2.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

3.  Potential markers that complement expression of CA125 in epithelial ovarian cancer.

Authors:  Daniel G Rosen; Lin Wang; J Neeley Atkinson; Yinhua Yu; Karen H Lu; Eleftherios P Diamandis; Ingegerd Hellstrom; Samuel C Mok; Jinsong Liu; Robert C Bast
Journal:  Gynecol Oncol       Date:  2005-08-02       Impact factor: 5.482

4.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

5.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  Usha Menon; Aleksandra Gentry-Maharaj; Rachel Hallett; Andy Ryan; Matthew Burnell; Aarti Sharma; Sara Lewis; Susan Davies; Susan Philpott; Alberto Lopes; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Mourad W Seif; Ian Scott; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Nazar N Amso; Simon Leeson; Derek Cruickshank; Alistair McGuire; Stuart Campbell; Lesley Fallowfield; Naveena Singh; Anne Dawnay; Steven J Skates; Mahesh Parmar; Ian Jacobs
Journal:  Lancet Oncol       Date:  2009-03-11       Impact factor: 41.316

6.  Coregistered three-dimensional ultrasound and photoacoustic imaging system for ovarian tissue characterization.

Authors:  Andres Aguirre; Puyun Guo; John Gamelin; Shikui Yan; Mary M Sanders; Molly Brewer; Quing Zhu
Journal:  J Biomed Opt       Date:  2009 Sep-Oct       Impact factor: 3.170

7.  Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

Authors:  Susan M Domchek; Tara M Friebel; Susan L Neuhausen; Theresa Wagner; Gareth Evans; Claudine Isaacs; Judy E Garber; Mary B Daly; Rosalind Eeles; Ellen Matloff; Gail E Tomlinson; Laura Van't Veer; Henry T Lynch; Olufunmilayo I Olopade; Barbara L Weber; Timothy R Rebbeck
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

8.  A 2-stage ovarian cancer screening strategy using the Risk of Ovarian Cancer Algorithm (ROCA) identifies early-stage incident cancers and demonstrates high positive predictive value.

Authors:  Karen H Lu; Steven Skates; Mary A Hernandez; Deepak Bedi; Therese Bevers; Leroy Leeds; Richard Moore; Cornelius Granai; Steven Harris; William Newland; Olasunkanmi Adeyinka; Jeremy Geffen; Michael T Deavers; Charlotte C Sun; Nora Horick; Herbert Fritsche; Robert C Bast
Journal:  Cancer       Date:  2013-08-26       Impact factor: 6.860

9.  Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers.

Authors:  Isaac Kinde; Chetan Bettegowda; Yuxuan Wang; Jian Wu; Nishant Agrawal; Ie-Ming Shih; Robert Kurman; Fanny Dao; Douglas A Levine; Robert Giuntoli; Richard Roden; James R Eshleman; Jesus Paula Carvalho; Suely Kazue Nagahashi Marie; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

10.  Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.

Authors:  Paul A Cohen; Nicola Flowers; Stephen Tong; Natalie Hannan; Mark D Pertile; Lisa Hui
Journal:  BMC Med       Date:  2016-08-24       Impact factor: 8.775
View more
  20 in total

Review 1.  Novel Approaches to Ovarian Cancer Screening.

Authors:  Denise R Nebgen; Karen H Lu; Robert C Bast
Journal:  Curr Oncol Rep       Date:  2019-07-26       Impact factor: 5.075

2.  Systematic review and meta-analysis of imaging differential diagnosis of benign and malignant ovarian tumors.

Authors:  Wen-Huan Wang; Chang-Bao Zheng; Jin-Niao Gao; Shang-Shang Ren; Guo-Yan Nie; Zhi-Qun Li
Journal:  Gland Surg       Date:  2022-02

Review 3.  Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer.

Authors:  Xianwen Hu; Dandan Li; Yujie Fu; Jiashen Zheng; Zelong Feng; Jiong Cai; Pan Wang
Journal:  Front Oncol       Date:  2022-06-15       Impact factor: 5.738

Review 4.  Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.

Authors:  Juliane M Liberto; Sheng-Yin Chen; Ie-Ming Shih; Tza-Huei Wang; Tian-Li Wang; Thomas R Pisanic
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

5.  NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype.

Authors:  Bing Xin; Kai-Qiang Ji; Yi-Si Liu; Xiao-Dong Zhao
Journal:  Reprod Sci       Date:  2020-10-30       Impact factor: 3.060

6.  HULC functions as an oncogene in ovarian carcinoma cells by negatively modulating miR-125a-3p.

Authors:  Ping Chu; Lina Xu; Haiying Su
Journal:  J Physiol Biochem       Date:  2019-03-13       Impact factor: 4.158

Review 7.  Should All Individuals Be Screened for Genetic Predisposition to Cancer?

Authors:  Sarah Wedderburn; Terri P McVeigh
Journal:  Genet Res (Camb)       Date:  2021-01-09       Impact factor: 1.588

8.  Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.

Authors:  Valéria Tavares; Ricardo Pinto; Joana Assis; Sara Coelho; Mariana Brandão; Sara Alves; Deolinda Pereira; Rui Medeiros
Journal:  Pharmacogenomics J       Date:  2020-11-07       Impact factor: 3.245

9.  Biomarkers and Strategies for Early Detection of Ovarian Cancer.

Authors:  Robert C Bast; Zhen Lu; Chae Young Han; Karen H Lu; Karen S Anderson; Charles W Drescher; Steven J Skates
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-13       Impact factor: 4.254

10.  Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes.

Authors:  Ricky Cordova; Kelli Kiekens; Susan Burrell; William Drake; Zaynah Kmeid; Photini Rice; Andrew Rocha; Sebastian Diaz; Shigehiro Yamada; Michael Yozwiak; Omar L Nelson; Gustavo C Rodriguez; John Heusinkveld; Ie-Ming Shih; David S Alberts; Jennifer K Barton
Journal:  J Biomed Opt       Date:  2021-07       Impact factor: 3.170
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.